| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |